Pages
U.S. a dim brightspot in the global economy
Juli Niemann Oct 9, 2012
The third-quarter earnings season kicked off today with an ominous warning about global growth from the IMF. A weak consolation for Americans is that we are the only major economy where the IMF expects decent growth in the next year.
Corporate earnings expected to disappoint
Mitchell Hartman Oct 9, 2012
Companies in the S&P 500 predict lower third-quarter earnings by a four-to-one margin.
Despite strong year, individuals pull back on stocks
Jeff Horwich Oct 8, 2012
After a brief uptick, the percent of households owning stock is back down to where it was at the start of the financial crisis, according to new numbers from the Investment Company Institute.
Earnings under spotlight as economy slows
Sally Herships Oct 8, 2012
Third-quarter earnings season begins this week, with some analysts predicting the first decline in S&P 500 profits since 2009.
Measuring the strength of the economy and the stock market
Jeff Horwich Sep 24, 2012
We've said it before, and we'll say it again: the economy and the stock market are not one and the same. The performance of the economy under a president is open to wide interpretation. The stock market, on the hand... Well, we can measure that.
Apple’s size can move markets up –- and down
Stacey Vanek Smith Sep 21, 2012
Everybody knows that Apple is big enough to move markets. This year, that’s been a boon -- but what if the iPhone 5 falters?
Astrology guides some financial traders
Heidi N. Moore Oct 30, 2012
When the moon is in the seventh house, what’s a Wall Street trader to do? Pay some $300 for a financial astrology newsletter -- to go with stock charts.
Staples loses sales, Target nabs a profit
Josh Brown Aug 15, 2012
Shares in the office supply store Staples are down 15 percent this morning after the company said its sales dropped 5.5 percent last quarter. Meanwhile, the discount retailer Target said it made a $700 million profit last quarter
Stock trading glitch spooks investors again
Heidi N. Moore Aug 2, 2012
Knight Capital’s faulty software sent trading haywire and could sink the brokerage firm. Is technology helping or hurting investor confidence?
Pfizer profits jump despite loss of Lipitor patent
Amy Scott Jul 31, 2012
Pfizer seems to be weathering the loss of its patent for Lipitor just fine. The drug company says its second quarter profit jumped 25 percent. That's despite lower revenue, and competition from generics for its cholesterol-fighting blockbuster.
